FDA Clearance Tracker · P990086-S003
HEALTHTRONICS OSSATRON
Last checked: Nov 20, 2026Latest source record: Mar 14, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Mar 14, 2003
Approved
Time to decision
494 days
Received Nov 5, 2001. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P990086-S003
- Device name
- HEALTHTRONICS OSSATRON
- Applicant
- Sanuwave, Inc.
- Applicant location
- Alpharetta, GA
- Received
- Nov 5, 2001
- Decided
- Mar 14, 2003
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P990086
Device type
- Device type
- Generator, shock-wave, for pain relief (NBN)
- Device class
- Class III
- Specialty
- Physical Medicine & Rehabilitation
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE HEALTHTRONICS OSSATRON. THE DEVICE IS INDICATED FOR USE FOR PERFORMING EXTRACORPOREAL SHOCK WAVE (ESW) TREATMENT IN PATIENTS WITH CHRONIC LATERAL EPICONDYLITIS (TENNIS ELBOW) THAT HAS FAILED TO RESPOND TO CONSERVATIVE TREATMENT. CHRONIC LATERAL EPICONDYLITIS IS DEFINED AS LATERAL EPICONDYLITIS THAT HAS PERSISTED FOR 6 MONTHS OR MORE WITH A HISTORY OF UNSUCCESSFUL CONSERVATIVE TREATMENT.
Source documents
Other decisions for Sanuwave, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- dermaPACE SystemNew device typeDe Novo
DEN160037 · Decided Dec 28, 2017 · 521 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.